SEHK:9995
SEHK:9995Biotechs

Does RemeGen’s Narrowed Net Loss and Rising Revenue Shift Sentiment on SEHK:9995’s Recovery Potential?

RemeGen Co., Ltd. reported earnings for the nine months ended September 30, 2025, with sales and revenue rising to CNY 1,719.83 million from CNY 1,208.87 million a year earlier, while its net loss narrowed to CNY 550.7 million from CNY 1,071.43 million. The company also reported that its basic and diluted loss per share from continuing operations dropped to CNY 1.01 from CNY 1.99 in the previous year. We'll explore how RemeGen’s reduced net loss and improved revenue shape its investment...
SEHK:700
SEHK:700Interactive Media and Services

Tencent (SEHK:700) Valuation in Focus After TanLIVE AI Climate Platform Expansion and Global Partnerships

Tencent Holdings (SEHK:700) has drawn fresh attention from investors after launching new AI-powered services on its TanLIVE climate innovation platform. The recent announcement highlights Tencent’s ongoing efforts to develop climate solutions in collaboration with major global partners. See our latest analysis for Tencent Holdings. Tencent’s new climate innovation launch is making waves at a time when its share price momentum is hard to ignore. With a year-to-date share price return of nearly...
SEHK:2252
SEHK:2252Medical Equipment

Shanghai MicroPort MedBot (Group) (SEHK:2252) Is Down 6.3% After Senior Leadership Resignations and Governance Overhaul—Has the Bull Case Changed?

Shanghai MicroPort MedBot (Group) recently announced the resignation of three senior board members, including the chairperson, and proposed amendments to its board structure and governance documents, pending approval at an extraordinary general meeting. These governance changes mark a significant moment for the company, as leadership transitions and board expansion could reshape decision-making processes and future growth initiatives. We'll explore how these multiple high-level resignations...
SEHK:2338
SEHK:2338Machinery

Will Weichai Power’s (SEHK:2338) Fuel Cell Push Reshape Its Competitive Edge in Power Generation?

On November 5, 2025, Ceres Power Holdings plc announced it has signed a manufacturing licence agreement with Weichai Power for the production of its solid oxide fuel cell technology, enabling Weichai to produce cells and stacks for stationary power systems in China targeting AI data centres, commercial buildings, and industrial sectors. This agreement not only expands Ceres' roster of manufacturing partners to four but also marks a shift for Weichai Power into advanced energy solutions that...
SEHK:9969
SEHK:9969Biotechs

InnoCare Pharma (SEHK:9969): Evaluating Valuation After Sales Growth and Pipeline Advances Spark Market Interest

InnoCare Pharma (SEHK:9969) just reported higher sales and a smaller net loss for the first nine months of 2025, while also advancing key drug candidates in its clinical pipeline. This combination is catching investor attention. See our latest analysis for InnoCare Pharma. Momentum has returned in a big way for InnoCare Pharma, with its share price rallying 5.08% over the past week and boasting a striking year-to-date gain of 165.38%. Even after a pullback in the last quarter, the total...
SEHK:2328
SEHK:2328Insurance

PICC P&C (SEHK:2328): Assessing Valuation After Interim Dividend Approval and Investor Day Updates

PICC Property and Casualty (SEHK:2328) recently held its Analyst and Investor Day, which followed the approval of an interim dividend for the first half of 2025. This timing brought renewed attention to the company’s financial health and strategic direction. See our latest analysis for PICC Property and Casualty. The combination of a freshly approved interim dividend and a recent Analyst and Investor Day appears to have strengthened investor confidence. This is reflected in PICC Property and...
SEHK:1585
SEHK:1585Auto

Is Yadea’s Launch of High-Speed Charging and Sodium-Ion Tech Reshaping Its Investment Case (SEHK:1585)?

At EICMA 2025, Yadea Group Holdings unveiled its latest high-performance electric motorcycles and an integrated charging ecosystem, debuting innovations such as the Velax series with ultra-fast charging, next-generation sodium-ion batteries, and a range of intelligent mobility solutions. A key highlight is Yadea’s focus on making rapid charging and sodium battery technology widely accessible, underlining its ambitions to accelerate sustainable electric mobility on a global scale. As Yadea...
SEHK:883
SEHK:883Oil and Gas

A Look at CNOOC (SEHK:883) Valuation Following Latest Earnings Report and Profit Decline

CNOOC (SEHK:883) just released its earnings report for the first nine months of 2025, highlighting a decline in both revenue and net income compared to the previous year. This development is catching investors’ attention. See our latest analysis for CNOOC. CNOOC's shares have had an impressive run, with a 20.7% share price return over the past month and a strong 44.4% total shareholder return for the past year, despite the recent earnings disappointment. Momentum remains solid, suggesting...
SEHK:467
SEHK:467Oil and Gas

United Energy Group (SEHK:467): Valuation Insights After Credit Rating and Egypt Acquisition Moves

United Energy Group (SEHK:467) has received a ‘BB-’ credit rating from Fitch for its proposed US dollar notes, shortly after acquiring Apex International Energy’s Egypt assets for USD150 million. These moves reflect management’s focus on expansion and refining its capital structure. See our latest analysis for United Energy Group. Following the acquisition news and Fitch's rating, investor sentiment appears to be shifting. United Energy Group boasts a robust year-to-date share price return of...
SEHK:1810
SEHK:1810Tech

Xiaomi (SEHK:1810): Assessing Valuation After Recent Share Price Pullback

Xiaomi (SEHK:1810) shares have been active in recent sessions, catching investor interest amid shifts in Hong Kong’s tech sector. Traders are considering how recent market conditions may affect Xiaomi’s performance and valuation in the coming months. See our latest analysis for Xiaomi. Xiaomi’s share price has pulled back by over 10% in the past month after some earlier momentum. It is still sitting on a remarkable year-to-date gain of nearly 28%. Even more striking, the stock’s one-year...
SEHK:1548
SEHK:1548Life Sciences

Genscript Biotech (SEHK:1548): Reviewing Valuation After Analyst and Investor Day Update

Genscript Biotech (SEHK:1548) just held its Analyst and Investor Day, a regular event where management updates shareholders on strategy and future plans. These sessions often spark renewed interest in the company’s growth prospects and valuation. See our latest analysis for Genscript Biotech. Following the Analyst and Investor Day, Genscript Biotech’s shares surged with a 1-day share price return of 5.86 percent. This added to its strong year-to-date momentum and suggested renewed investor...
SEHK:2600
SEHK:2600Metals and Mining

A Fresh Look at Chalco (SEHK:2600) Valuation as Guinea Mining Rules Reshape Aluminum Supply Chains

Recent shifts in Guinea's mining sector, including new local processing mandates and transferred concessions, could impact global aluminum supply chains. For Aluminum Corporation of China (SEHK:2600), these changes may affect input costs and future supply stability. See our latest analysis for Aluminum Corporation of China. Aluminum Corporation of China’s momentum has been nothing short of remarkable. After a steady climb throughout the year, the share price has spiked by 161.85%...
SEHK:6855
SEHK:6855Biotechs

Ascentage Pharma (SEHK:6855): Evaluating Valuation After ASH Meeting Spotlights Pipeline Progress

Ascentage Pharma Group International (SEHK:6855) saw attention rise after announcing that new clinical and preclinical results on olverembatinib, lisaftoclax, and APG-5918 will be featured at the 67th ASH Annual Meeting. This recognition for its drug candidates highlights the company’s development programs and keeps them in focus for investors. See our latest analysis for Ascentage Pharma Group International. This spotlight at ASH comes after a year of strong momentum for Ascentage Pharma...
SEHK:1398
SEHK:1398Banks

ICBC (SEHK:1398) Valuation: Assessing Impact of Fresh RMB40 Billion AT1 Capital Raise on Growth Prospects

Industrial and Commercial Bank of China (SEHK:1398) just completed a major capital raising, issuing RMB40 billion in undated Additional Tier 1 Capital Bonds. This move increases the bank’s financial cushion for future expansion. See our latest analysis for Industrial and Commercial Bank of China. ICBC’s recent surge stands out, with its share price jumping 16.25% over the past month and 35.67% year-to-date, reflecting renewed optimism as capital strength and dividend announcements boost...
SEHK:6088
SEHK:6088Electronic

How Stronger Results and Governance Changes at FIT Hon Teng (SEHK:6088) Have Changed Its Investment Story

FIT Hon Teng Limited has released its unaudited financial results for the nine months ending September 30, 2025, reporting increases in both current and non-current assets as well as higher revenue and net profit from continuing operations. A newly announced board and committee structure aims to further strengthen governance and support long-term corporate growth initiatives. We’ll explore how FIT Hon Teng’s recent financial improvements and corporate governance changes may influence its...
SEHK:1
SEHK:1Industrials

Assessing CK Hutchison Holdings (SEHK:1) Valuation After New Telecom Subsidiary Update Spurs Investor Interest

CK Hutchison Holdings (SEHK:1) has published a quarterly trading update for its telecom subsidiary, featuring unaudited financial results for the quarter ended September 30, 2025. The company urged investors to treat this data with caution. See our latest analysis for CK Hutchison Holdings. Following the telecom update, CK Hutchison Holdings’ shares have surged, with a 34.6% share price return year to date and a 44.9% total shareholder return over the past year. With momentum building on...
SEHK:880
SEHK:880Hospitality

How SJM Holdings' (SEHK:880) Sharp Profit Decline Will Impact Investor Sentiment and Strategy

SJM Holdings recently reported its third quarter 2025 results, revealing a 15% decline in adjusted EBITDA and a 91.1% decrease in net profit year-on-year, with both total net revenue and net gaming revenue also dropping compared to the prior year. This sharp drop in profitability highlights a challenging period for the company's core gaming operations in Macau, pointing to underlying headwinds in the operating environment. We'll explore how the significant year-on-year decline in...
SEHK:23
SEHK:23Banks

Could AI Automation Set a New Competitive Standard for Bank of East Asia (SEHK:23)?

CLPS Incorporation recently announced its collaboration with The Bank of East Asia to conduct a Proof-of-Concept for Nibot, an advanced AI agent integrating Robotic Process Automation and Generative AI within banking operations. This initiative highlights a forward-thinking approach by leveraging AI to boost efficiency, compliance, and risk management in the financial sector. We'll explore how the adoption of intelligent automation and AI-driven compliance solutions may influence Bank of...
SEHK:9926
SEHK:9926Biotechs

The Bull Case For Akeso (SEHK:9926) Could Change Following New Oncology Pipeline Milestones and Clinical Results

In early November 2025, Akeso announced a series of pipeline milestones, including the first patient dosing in a Phase I trial of its mRNA vaccine AK154, the presentation of promising Overall Survival results for ivonescimab in EGFR-mutated non-small cell lung cancer at SITC, and new preclinical data for its novel antibody AK135. The rapid progress across both late-stage and innovative early-stage assets underscores Akeso's efforts to expand its oncology portfolio while solidifying its...